- Published on
Infectious Disease and Microbiology - Lung abscess
A lung abscess is a localized collection of pus within the lung parenchyma, resulting in a cavity formed by necrosis of lung tissue due to microbial infection. It may present as a single large cavity or as multiple smaller abscesses, the latter often referred to as necrotizing pneumonia. Lung abscesses can be classified as primary, occurring in otherwise healthy individuals, or secondary, associated with underlying conditions such as malignancy, bronchiectasis, or immunosuppression. Although more common in the pre-antibiotic era, lung abscesses are now relatively uncommon but remain clinically significant due to potential complications.
The most important risk factor is aspiration of oropharyngeal contents, particularly in individuals with impaired consciousness, dysphagia, or poor dental hygiene. Conditions such as alcoholism, general anesthesia, seizures, and gastroesophageal reflux disease increase the risk of aspiration. Periodontal disease plays a major role by providing a source of anaerobic bacteria. Other risk factors include airway obstruction, immunocompromised states such as HIV or diabetes, and hematogenous spread from infections like right-sided endocarditis.
Pathophysiologically, microorganisms—most commonly anaerobic bacteria—enter the lung through aspiration and proliferate in areas with poor clearance. This leads to tissue necrosis and cavity formation. Less commonly, abscesses arise from septic emboli traveling through the bloodstream. The most frequent causative organisms include anaerobes such as Peptostreptococcus, Fusobacterium, Prevotella, and Bacteroides species, often in combination with aerobic bacteria. Aerobic pathogens include Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa, with resistant organisms such as MRSA being increasingly recognized.
Clinically, patients typically present with cough producing foul-smelling, purulent sputum, fever, and pleuritic chest pain. In chronic cases, symptoms may persist for weeks and include weight loss, fatigue, night sweats, and malaise. Physical examination may reveal tachycardia, tachypnea, and abnormal lung findings such as crackles, decreased breath sounds, or signs of consolidation. Digital clubbing may develop in longstanding disease.
Diagnosis involves laboratory and imaging studies. Blood tests often show leukocytosis, while sputum cultures may be inconclusive, especially for anaerobic infections. Chest imaging is essential, with radiographs typically showing a cavity with an air–fluid level. CT scanning provides better anatomical detail and helps identify underlying causes such as obstruction or malignancy. Additional procedures such as bronchoscopy or needle aspiration may be required in atypical or nonresponsive cases.
Treatment consists primarily of prolonged antibiotic therapy targeting both anaerobic and aerobic organisms. First-line regimens include clindamycin or beta-lactam/beta-lactamase inhibitor combinations such as ampicillin-sulbactam, followed by oral therapy once clinical improvement occurs. The duration of therapy may extend from several weeks to months, depending on radiologic resolution. Supportive measures such as postural drainage and pulmonary physiotherapy are important adjuncts. In cases unresponsive to medical therapy, percutaneous or surgical drainage may be necessary.
The prognosis is generally good with appropriate treatment, although mortality ranges from 5% to 15%. Poor prognostic factors include large cavity size, delayed diagnosis, underlying comorbidities, and infection with resistant organisms. Complications may include empyema, massive hemoptysis, pneumothorax, and dissemination leading to conditions such as brain abscess. Careful follow-up with serial imaging is required to ensure resolution of the infection.
A lung abscess is a localized collection of pus within the lung parenchyma, resulting in a cavity formed by necrosis of lung tissue due to microbial infection. It may present as a single large cavity or as multiple smaller abscesses, the latter often referred to as necrotizing pneumonia. Lung abscesses can be classified as primary, occurring in otherwise healthy individuals, or secondary, associated with underlying conditions such as malignancy, bronchiectasis, or immunosuppression. Although more common in the pre-antibiotic era, lung abscesses are now relatively uncommon but remain clinically significant due to potential complications.
The most important risk factor is aspiration of oropharyngeal contents, particularly in individuals with impaired consciousness, dysphagia, or poor dental hygiene. Conditions such as alcoholism, general anesthesia, seizures, and gastroesophageal reflux disease increase the risk of aspiration. Periodontal disease plays a major role by providing a source of anaerobic bacteria. Other risk factors include airway obstruction, immunocompromised states such as HIV or diabetes, and hematogenous spread from infections like right-sided endocarditis.
Pathophysiologically, microorganisms—most commonly anaerobic bacteria—enter the lung through aspiration and proliferate in areas with poor clearance. This leads to tissue necrosis and cavity formation. Less commonly, abscesses arise from septic emboli traveling through the bloodstream. The most frequent causative organisms include anaerobes such as Peptostreptococcus, Fusobacterium, Prevotella, and Bacteroides species, often in combination with aerobic bacteria. Aerobic pathogens include Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa, with resistant organisms such as MRSA being increasingly recognized.
Clinically, patients typically present with cough producing foul-smelling, purulent sputum, fever, and pleuritic chest pain. In chronic cases, symptoms may persist for weeks and include weight loss, fatigue, night sweats, and malaise. Physical examination may reveal tachycardia, tachypnea, and abnormal lung findings such as crackles, decreased breath sounds, or signs of consolidation. Digital clubbing may develop in longstanding disease.
Diagnosis involves laboratory and imaging studies. Blood tests often show leukocytosis, while sputum cultures may be inconclusive, especially for anaerobic infections. Chest imaging is essential, with radiographs typically showing a cavity with an air–fluid level. CT scanning provides better anatomical detail and helps identify underlying causes such as obstruction or malignancy. Additional procedures such as bronchoscopy or needle aspiration may be required in atypical or nonresponsive cases.
Treatment consists primarily of prolonged antibiotic therapy targeting both anaerobic and aerobic organisms. First-line regimens include clindamycin or beta-lactam/beta-lactamase inhibitor combinations such as ampicillin-sulbactam, followed by oral therapy once clinical improvement occurs. The duration of therapy may extend from several weeks to months, depending on radiologic resolution. Supportive measures such as postural drainage and pulmonary physiotherapy are important adjuncts. In cases unresponsive to medical therapy, percutaneous or surgical drainage may be necessary.
The prognosis is generally good with appropriate treatment, although mortality ranges from 5% to 15%. Poor prognostic factors include large cavity size, delayed diagnosis, underlying comorbidities, and infection with resistant organisms. Complications may include empyema, massive hemoptysis, pneumothorax, and dissemination leading to conditions such as brain abscess. Careful follow-up with serial imaging is required to ensure resolution of the infection.
- Published on
Infectious Disease and Microbiology - Listeriosis
Listeriosis is an infection caused by the gram-positive bacterium Listeria monocytogenes, which is commonly transmitted through contaminated food such as unpasteurized dairy products, processed meats, and raw vegetables. Although many individuals may carry the organism asymptomatically in their gastrointestinal tract, it can cause serious invasive disease, particularly in vulnerable populations. The infection may present in several clinical forms, including febrile gastroenteritis, central nervous system involvement, bacteremia, infection during pregnancy, neonatal infection, and focal infections in various organs.
The disease occurs worldwide and may appear as sporadic cases or outbreaks, often linked to food contamination. While listeriosis can affect healthy individuals, those at higher risk include neonates, elderly individuals, pregnant women, and immunocompromised patients. Pregnancy-associated listeriosis is particularly significant, accounting for a substantial proportion of cases and often presenting with mild, flu-like symptoms in the mother but potentially leading to severe fetal complications such as miscarriage, stillbirth, or neonatal infection.
The pathophysiology varies depending on the clinical syndrome. In healthy individuals, ingestion of the organism may lead to a self-limited febrile gastroenteritis. However, in high-risk groups, the bacteria can invade the bloodstream and spread to the central nervous system, causing meningitis or meningoencephalitis. These CNS infections may present subtly, often with mild fever and altered mental status rather than classic meningeal signs. In neonates, infection may present early with sepsis or pneumonia, or later with meningitis, and in severe cases can manifest as granulomatosis infantiseptica, a disseminated and life-threatening condition.
Diagnosis is based on clinical suspicion supported by laboratory findings. Blood cultures and cerebrospinal fluid analysis are key in detecting invasive disease. Imaging, particularly brain MRI, is useful in patients with neurological symptoms. Stool cultures are generally not helpful, and there are no specific clinical signs that definitively establish the diagnosis, making awareness of risk factors and presentations essential.
Treatment depends on the severity and form of the disease. Mild gastroenteritis in immunocompetent individuals may not require antibiotics, whereas invasive disease requires prompt antimicrobial therapy. First-line treatment typically includes ampicillin or penicillin G, often combined with gentamicin in severe cases. Trimethoprim-sulfamethoxazole is an alternative, particularly in patients with allergies. Treatment duration varies from a few days in mild cases to several weeks in CNS or systemic infections. Hospitalization is required for patients with invasive disease.
The prognosis of listeriosis varies widely. While mild forms have an excellent outcome, invasive infections, especially meningitis and endocarditis, are associated with high mortality rates. Complications may include neurological deficits, seizures, and systemic spread of infection. In pregnancy, adverse fetal outcomes are a major concern. Prevention focuses on proper food handling, avoiding high-risk foods such as unpasteurized dairy products, and maintaining good hygiene practices, particularly in high-risk populations.
Listeriosis is an infection caused by the gram-positive bacterium Listeria monocytogenes, which is commonly transmitted through contaminated food such as unpasteurized dairy products, processed meats, and raw vegetables. Although many individuals may carry the organism asymptomatically in their gastrointestinal tract, it can cause serious invasive disease, particularly in vulnerable populations. The infection may present in several clinical forms, including febrile gastroenteritis, central nervous system involvement, bacteremia, infection during pregnancy, neonatal infection, and focal infections in various organs.
The disease occurs worldwide and may appear as sporadic cases or outbreaks, often linked to food contamination. While listeriosis can affect healthy individuals, those at higher risk include neonates, elderly individuals, pregnant women, and immunocompromised patients. Pregnancy-associated listeriosis is particularly significant, accounting for a substantial proportion of cases and often presenting with mild, flu-like symptoms in the mother but potentially leading to severe fetal complications such as miscarriage, stillbirth, or neonatal infection.
The pathophysiology varies depending on the clinical syndrome. In healthy individuals, ingestion of the organism may lead to a self-limited febrile gastroenteritis. However, in high-risk groups, the bacteria can invade the bloodstream and spread to the central nervous system, causing meningitis or meningoencephalitis. These CNS infections may present subtly, often with mild fever and altered mental status rather than classic meningeal signs. In neonates, infection may present early with sepsis or pneumonia, or later with meningitis, and in severe cases can manifest as granulomatosis infantiseptica, a disseminated and life-threatening condition.
Diagnosis is based on clinical suspicion supported by laboratory findings. Blood cultures and cerebrospinal fluid analysis are key in detecting invasive disease. Imaging, particularly brain MRI, is useful in patients with neurological symptoms. Stool cultures are generally not helpful, and there are no specific clinical signs that definitively establish the diagnosis, making awareness of risk factors and presentations essential.
Treatment depends on the severity and form of the disease. Mild gastroenteritis in immunocompetent individuals may not require antibiotics, whereas invasive disease requires prompt antimicrobial therapy. First-line treatment typically includes ampicillin or penicillin G, often combined with gentamicin in severe cases. Trimethoprim-sulfamethoxazole is an alternative, particularly in patients with allergies. Treatment duration varies from a few days in mild cases to several weeks in CNS or systemic infections. Hospitalization is required for patients with invasive disease.
The prognosis of listeriosis varies widely. While mild forms have an excellent outcome, invasive infections, especially meningitis and endocarditis, are associated with high mortality rates. Complications may include neurological deficits, seizures, and systemic spread of infection. In pregnancy, adverse fetal outcomes are a major concern. Prevention focuses on proper food handling, avoiding high-risk foods such as unpasteurized dairy products, and maintaining good hygiene practices, particularly in high-risk populations.
- Published on
Infectious Disease and Microbiology - Lice
Lice infestation, also known as pediculosis, is caused by ectoparasitic insects of the order Phthiraptera that live on human hair and skin. It is not an infection but an infestation, involving three main types depending on location: head lice, body lice, and pubic lice. The causative organisms include Pediculus humanus capitis, Pediculus humanus corporis, and Phthirus pubis. These parasites feed on human blood and complete their life cycle entirely on the host, with eggs (nits) hatching into nymphs that mature into adults within a few weeks.
Head lice infestation is particularly common among school-aged children and spreads mainly through close personal contact. It is not strongly linked to poor hygiene but is associated with crowding and household size. Body lice are more commonly seen in individuals with poor hygiene, especially among homeless populations or in crowded environments such as refugee camps. Pubic lice are typically transmitted through sexual contact and are therefore considered a sexually transmitted condition, often associated with other sexually transmitted infections.
The main symptom of lice infestation is pruritus, which results from a hypersensitivity reaction to lice saliva. The itching varies depending on the site of infestation and may lead to excoriations and secondary bacterial infections. Physical examination is diagnostic, revealing live lice or nits attached to hair shafts or clothing fibers. In head lice, careful combing of wet hair can improve detection. Pubic lice may also affect other coarse hair regions, including eyelashes, and characteristic bluish-gray skin lesions known as maculae ceruleae may appear.
Diagnosis is clinical and does not require laboratory testing. However, in cases of pubic lice, evaluation for coexisting sexually transmitted diseases is recommended. Body lice infestations may be associated with transmission of certain pathogens, including Bartonella quintana and, less commonly, Rickettsia prowazekii, making recognition important in vulnerable populations.
Treatment primarily involves topical insecticides, with permethrin 1% being the first-line therapy for most infestations. Reapplication after 7 to 10 days is often necessary to eradicate newly hatched lice. Alternative treatments include malathion, lindane (with caution due to potential toxicity), and oral ivermectin in selected cases. Proper application technique is essential for treatment success, as resistance or improper use may lead to persistence of infestation.
Supportive measures include washing clothing, bedding, and personal items in hot water, particularly for body lice. For pubic lice affecting the eyelashes, petroleum jelly may be used. Mechanical removal of lice and nits can be helpful but is generally less effective when used alone. The prognosis is excellent with appropriate treatment, although reinfestation can occur if contacts are not treated simultaneously.
Complications are usually mild and include secondary bacterial skin infections due to scratching. In certain cases, particularly with body lice, there is a risk of transmission of systemic infections. Psychological distress, especially among children and caregivers, is also a notable consequence of infestation.
Lice infestation, also known as pediculosis, is caused by ectoparasitic insects of the order Phthiraptera that live on human hair and skin. It is not an infection but an infestation, involving three main types depending on location: head lice, body lice, and pubic lice. The causative organisms include Pediculus humanus capitis, Pediculus humanus corporis, and Phthirus pubis. These parasites feed on human blood and complete their life cycle entirely on the host, with eggs (nits) hatching into nymphs that mature into adults within a few weeks.
Head lice infestation is particularly common among school-aged children and spreads mainly through close personal contact. It is not strongly linked to poor hygiene but is associated with crowding and household size. Body lice are more commonly seen in individuals with poor hygiene, especially among homeless populations or in crowded environments such as refugee camps. Pubic lice are typically transmitted through sexual contact and are therefore considered a sexually transmitted condition, often associated with other sexually transmitted infections.
The main symptom of lice infestation is pruritus, which results from a hypersensitivity reaction to lice saliva. The itching varies depending on the site of infestation and may lead to excoriations and secondary bacterial infections. Physical examination is diagnostic, revealing live lice or nits attached to hair shafts or clothing fibers. In head lice, careful combing of wet hair can improve detection. Pubic lice may also affect other coarse hair regions, including eyelashes, and characteristic bluish-gray skin lesions known as maculae ceruleae may appear.
Diagnosis is clinical and does not require laboratory testing. However, in cases of pubic lice, evaluation for coexisting sexually transmitted diseases is recommended. Body lice infestations may be associated with transmission of certain pathogens, including Bartonella quintana and, less commonly, Rickettsia prowazekii, making recognition important in vulnerable populations.
Treatment primarily involves topical insecticides, with permethrin 1% being the first-line therapy for most infestations. Reapplication after 7 to 10 days is often necessary to eradicate newly hatched lice. Alternative treatments include malathion, lindane (with caution due to potential toxicity), and oral ivermectin in selected cases. Proper application technique is essential for treatment success, as resistance or improper use may lead to persistence of infestation.
Supportive measures include washing clothing, bedding, and personal items in hot water, particularly for body lice. For pubic lice affecting the eyelashes, petroleum jelly may be used. Mechanical removal of lice and nits can be helpful but is generally less effective when used alone. The prognosis is excellent with appropriate treatment, although reinfestation can occur if contacts are not treated simultaneously.
Complications are usually mild and include secondary bacterial skin infections due to scratching. In certain cases, particularly with body lice, there is a risk of transmission of systemic infections. Psychological distress, especially among children and caregivers, is also a notable consequence of infestation.
- Published on
Infectious Disease and Microbiology - Leptospirosis
Leptospirosis is a zoonotic infectious disease caused by the spirochete Leptospira interrogans. It is transmitted primarily through contact with water, soil, or vegetation contaminated with the urine of infected animals, particularly rodents, which serve as the main reservoir. The organism enters the body through abraded skin or mucous membranes and disseminates hematogenously, affecting multiple organs. The disease is globally distributed and often underdiagnosed, with many infections remaining asymptomatic or presenting as nonspecific febrile illness.
Epidemiologically, leptospirosis is more common in tropical and subtropical regions, though it occurs worldwide. It is associated with occupational and recreational exposure, affecting farmers, sewer workers, veterinarians, and individuals exposed to contaminated water such as swimmers or campers. Outbreaks are often linked to flooding and poor sanitation, especially in urban slum settings. The incubation period typically ranges from 1 to 2 weeks but can vary from a few days to several weeks.
Clinically, leptospirosis presents with a wide spectrum of manifestations. The anicteric form is more common and characterized by fever, chills, severe myalgia (especially in the calf muscles), headache, and conjunctival suffusion. The disease may be biphasic, with an initial septicemic phase followed by an immune phase involving meningitis or other organ systems. In severe cases, patients develop icteric leptospirosis, also known as Weil’s syndrome, which is marked by jaundice, renal failure, and hemorrhagic complications. Neurological, respiratory, and gastrointestinal symptoms may also occur, reflecting multisystem involvement.
Diagnosis relies on a combination of clinical suspicion and laboratory testing. Direct visualization of leptospires may be possible using dark-field microscopy in blood, urine, or cerebrospinal fluid early in the disease. Serologic testing, particularly the microscopic agglutination test, is the reference standard, while detection of IgM antibodies and PCR-based methods provide additional diagnostic support. Laboratory abnormalities often include thrombocytopenia, elevated liver enzymes, renal dysfunction, and increased creatine phosphokinase levels. Imaging studies such as chest radiography may be necessary in patients with pulmonary involvement.
Treatment depends on disease severity. Mild cases can be managed with oral antibiotics such as doxycycline or azithromycin, whereas severe disease requires intravenous therapy, most commonly with penicillin G or ceftriaxone for approximately 7 days. Supportive care is crucial, especially in cases complicated by renal failure or respiratory distress, and specialist consultation may be necessary. Early initiation of antibiotics significantly improves outcomes.
The prognosis is generally favorable in mild disease, but severe leptospirosis carries a significant mortality risk, particularly when associated with hepatic and renal failure. Complications include hepatorenal syndrome, acute respiratory distress syndrome, myocarditis, and severe hemorrhage. Preventive measures focus on reducing exposure, including rodent control, use of protective clothing, and in selected high-risk individuals, chemoprophylaxis with doxycycline.
Leptospirosis is a zoonotic infectious disease caused by the spirochete Leptospira interrogans. It is transmitted primarily through contact with water, soil, or vegetation contaminated with the urine of infected animals, particularly rodents, which serve as the main reservoir. The organism enters the body through abraded skin or mucous membranes and disseminates hematogenously, affecting multiple organs. The disease is globally distributed and often underdiagnosed, with many infections remaining asymptomatic or presenting as nonspecific febrile illness.
Epidemiologically, leptospirosis is more common in tropical and subtropical regions, though it occurs worldwide. It is associated with occupational and recreational exposure, affecting farmers, sewer workers, veterinarians, and individuals exposed to contaminated water such as swimmers or campers. Outbreaks are often linked to flooding and poor sanitation, especially in urban slum settings. The incubation period typically ranges from 1 to 2 weeks but can vary from a few days to several weeks.
Clinically, leptospirosis presents with a wide spectrum of manifestations. The anicteric form is more common and characterized by fever, chills, severe myalgia (especially in the calf muscles), headache, and conjunctival suffusion. The disease may be biphasic, with an initial septicemic phase followed by an immune phase involving meningitis or other organ systems. In severe cases, patients develop icteric leptospirosis, also known as Weil’s syndrome, which is marked by jaundice, renal failure, and hemorrhagic complications. Neurological, respiratory, and gastrointestinal symptoms may also occur, reflecting multisystem involvement.
Diagnosis relies on a combination of clinical suspicion and laboratory testing. Direct visualization of leptospires may be possible using dark-field microscopy in blood, urine, or cerebrospinal fluid early in the disease. Serologic testing, particularly the microscopic agglutination test, is the reference standard, while detection of IgM antibodies and PCR-based methods provide additional diagnostic support. Laboratory abnormalities often include thrombocytopenia, elevated liver enzymes, renal dysfunction, and increased creatine phosphokinase levels. Imaging studies such as chest radiography may be necessary in patients with pulmonary involvement.
Treatment depends on disease severity. Mild cases can be managed with oral antibiotics such as doxycycline or azithromycin, whereas severe disease requires intravenous therapy, most commonly with penicillin G or ceftriaxone for approximately 7 days. Supportive care is crucial, especially in cases complicated by renal failure or respiratory distress, and specialist consultation may be necessary. Early initiation of antibiotics significantly improves outcomes.
The prognosis is generally favorable in mild disease, but severe leptospirosis carries a significant mortality risk, particularly when associated with hepatic and renal failure. Complications include hepatorenal syndrome, acute respiratory distress syndrome, myocarditis, and severe hemorrhage. Preventive measures focus on reducing exposure, including rodent control, use of protective clothing, and in selected high-risk individuals, chemoprophylaxis with doxycycline.
- Published on
Infectious Disease and Microbiology
Kawasaki syndrome (Kawasaki disease, KD)
Kawasaki syndrome is an acute, self-limited systemic vasculitis that primarily affects young children, especially those under 5 years of age. It is also known as mucocutaneous lymph node syndrome. Although the disease often resolves on its own, it is clinically significant because it can lead to serious cardiovascular complications, particularly coronary artery aneurysms.
The disease occurs worldwide but is most common in Japan, with most cases seen in children younger than 5 years. It can occur throughout the year, with peaks during winter and spring. Risk factors include recent respiratory infections and environmental exposures such as dust and mites. Genetic susceptibility also plays a role, with involvement of pathways such as caspase-3 and TGF-beta.
Kawasaki syndrome involves inflammation of medium and small blood vessels. In the early stage, there is endothelial swelling and inflammation, which later progresses to widespread systemic inflammation affecting multiple organs, especially the heart. Although the exact cause remains unknown, the condition is believed to be triggered by an infectious agent, possibly through a superantigen-mediated immune response.
Clinically, the diagnosis is based on the presence of fever lasting at least five days along with characteristic features. These include a polymorphous rash, bilateral non-purulent conjunctivitis, oral changes such as cracked lips and strawberry tongue, swelling and redness of the hands and feet followed by peeling, and cervical lymphadenopathy. Incomplete forms of the disease may occur and should still be treated if suspected. Other symptoms may include irritability, joint pain, myocarditis, pericarditis, aseptic meningitis, and gastrointestinal symptoms.
Laboratory findings commonly show anemia, leukocytosis, and thrombocytosis, particularly in later stages. Inflammatory markers such as ESR and CRP are elevated, and hypoalbuminemia and elevated liver enzymes may also be present. Echocardiography is essential to evaluate for coronary artery involvement, while ECG may reveal arrhythmias or other cardiac changes.
Management should be initiated promptly to reduce the risk of complications. The mainstay of treatment is intravenous immunoglobulin (IVIG), given as a single high-dose infusion, with a repeat dose if fever persists. Aspirin is also used, initially at high doses for its anti-inflammatory effect and later at lower doses for its antiplatelet properties. In resistant cases, corticosteroids or agents such as infliximab may be used. Patients with coronary complications may require anticoagulation and specialist cardiac care.
The prognosis is generally good when treated early. Without treatment, a significant proportion of patients develop coronary artery aneurysms, but this risk is markedly reduced with timely therapy. Long-term follow-up with echocardiography is important, especially in those with cardiac involvement.
Complications are mainly cardiovascular and include coronary artery aneurysms, myocardial infarction, myocarditis, and pericarditis, with myocardial infarction being the most common cause of death. Non-cardiac complications may include hearing loss, arthritis, pneumonitis, and macrophage activation syndrome.
- Published on
Infectious Disease and Microbiology - Keratitis
Keratitis refers to inflammation of the cornea that may be caused by infectious or noninfectious processes. Infectious keratitis can result from bacteria, viruses, fungi, or parasites, and bacterial keratitis is often referred to as a corneal ulcer. A major global cause of keratitis-related blindness is trachoma due to Chlamydia trachomatis, which leads to chronic inflammation, eyelid deformities, and corneal scarring.
The condition occurs worldwide, with bacterial keratitis being more common among contact lens users. Risk factors include disruption of the corneal epithelial surface, poor contact lens hygiene, overnight lens use, and ocular trauma. In critically ill patients, factors such as inability to close the eyes, reduced blinking, and dry eye contribute to risk. Fungal keratitis is more common in warm climates and often follows trauma with plant material, while trachoma is associated with poor hygiene and limited access to water.
The pathophysiology involves a break in the corneal epithelium that allows microorganisms to enter and proliferate in the corneal stroma. Some organisms possess adhesins that facilitate attachment to corneal cells. Viral causes such as Herpes simplex virus type 1 can remain latent in the trigeminal ganglion and reactivate, leading to recurrent disease. Similarly, Varicella zoster virus may reactivate later in life, causing herpes zoster ophthalmicus when the trigeminal nerve is involved.
A wide range of organisms can cause keratitis. Bacterial causes include Pseudomonas, Staphylococcus, and Streptococcus species, with Pseudomonas being particularly aggressive in contact lens users. Viral causes include HSV and VZV, with HSV producing characteristic dendritic lesions. Fungal organisms such as Aspergillus and Fusarium cause more indolent infections, while parasites such as Acanthamoeba can produce severe pain and characteristic ring-shaped infiltrates.
Patients typically present with eye pain, redness, foreign body sensation, photophobia, tearing, discharge, and reduced vision. Severe pain that is disproportionate to clinical findings is suggestive of Acanthamoeba infection. Viral keratitis may lead to reduced corneal sensation. Herpes zoster ophthalmicus may be preceded by a flu-like illness and is associated with a dermatomal rash, especially involving the tip of the nose.
On examination, slit-lamp findings include epithelial defects, stromal infiltrates, and anterior chamber inflammation. Fluorescein staining highlights epithelial defects. Severe cases may show hypopyon. Bacterial ulcers may appear as rapidly spreading infiltrates, while fungal keratitis often shows feathery borders and satellite lesions. HSV infection classically produces branching dendritic ulcers, while late Acanthamoeba infection may show a ring infiltrate.
Diagnosis is primarily clinical but supported by laboratory studies. Corneal scrapings are obtained for staining and culture to identify the causative organism. Special stains and media are used depending on suspected pathogens. PCR and viral testing may be used for herpetic infections, while confocal microscopy can help identify Acanthamoeba cysts.
Management depends on the underlying cause but must be initiated promptly. Suspected bacterial keratitis requires immediate empiric broad-spectrum topical antibiotics, often administered hourly. Severe cases may require fortified antibiotic drops. Fungal keratitis is treated with topical antifungals such as natamycin or amphotericin B, often for prolonged periods. Acanthamoeba infections require specific agents such as polyhexamethylene biguanide and are difficult to eradicate. Viral keratitis due to HSV is treated with topical antivirals, while deeper stromal disease may require cautious use of topical steroids along with antiviral coverage. Herpes zoster ophthalmicus is treated with systemic antiviral therapy.
Prognosis depends on the severity, location, and timeliness of treatment. Early treatment generally leads to good outcomes, but delayed therapy can result in significant visual impairment. Complications include corneal scarring, thinning, perforation, and secondary infections such as endophthalmitis. Chronic or recurrent infections, particularly with HSV, may lead to permanent visual loss and require surgical intervention such as corneal transplantation.
- Published on
Infectious Disease and Microbiology - Leishmaniasis
Leishmaniasis is a parasitic disease caused by protozoa of the genus Leishmania and transmitted through the bite of infected sandflies. It presents in three main clinical forms: cutaneous, mucosal, and visceral, with manifestations depending largely on the host immune response and the infecting species. The disease is widespread, with millions of cases globally and hundreds of millions of people at risk, particularly in tropical and subtropical regions.
Transmission occurs when infected sandflies inoculate promastigotes into the skin. These are taken up by macrophages, where they transform into amastigotes and multiply intracellularly. The parasites preferentially infect cells of the reticuloendothelial system. Disease severity is influenced by parasite burden, species type, and the host’s immune status. Immunocompromised individuals, especially those with HIV, are at increased risk of severe disease.
Cutaneous leishmaniasis typically begins as a papule at the site of the bite, which gradually enlarges, crusts, and ulcerates. The ulcer is usually painless, with raised borders and a granulating base, and may persist for months or even years. Mucosal leishmaniasis, most commonly associated with Leishmania braziliensis, affects the mucous membranes of the nose, mouth, and throat, potentially causing destructive lesions such as nasal septum perforation and voice changes.
Visceral leishmaniasis, also known as kala-azar, is the most severe form and is commonly caused by Leishmania donovani and Leishmania infantum. It presents with prolonged fever, weight loss, hepatosplenomegaly, anemia, and pancytopenia. Without treatment, it carries a high mortality rate. In advanced cases, patients may develop cachexia, edema, and profound immune dysfunction.
Diagnosis is confirmed by demonstrating the parasite in tissue samples such as bone marrow, spleen, liver, or skin lesions. Bone marrow aspiration is commonly used for visceral disease. PCR and serologic tests can support the diagnosis, particularly in visceral leishmaniasis, while skin tests are more useful in epidemiologic studies or cutaneous forms.
Treatment depends on the form and severity of disease. Liposomal amphotericin B is the treatment of choice for visceral leishmaniasis. Other agents include pentavalent antimonials, pentamidine, and newer oral therapies such as miltefosine. Many cases of cutaneous leishmaniasis resolve spontaneously, although treatment may be required for cosmetic reasons or severe disease. Mucosal disease requires systemic therapy due to its destructive nature.
The prognosis varies by form. Cutaneous disease generally has a good outcome, although scarring may occur. Visceral leishmaniasis is life-threatening if untreated but responds well to appropriate therapy. Mucosal disease can lead to significant morbidity and, in some cases, mortality. Complications include relapse, particularly in immunocompromised patients, and adverse effects from treatment such as toxicity from antimonial drugs.
- Published on
Infectious Disease and Microbiology - Larva migrans syndromes
Larva migrans syndromes represent a group of conditions caused by the migration of helminth larvae through human tissues, affecting the skin, internal organs, or eyes. These syndromes include cutaneous, visceral, and ocular forms, depending on where the larvae migrate. Humans are accidental hosts, and the parasites are unable to complete their life cycle, leading instead to tissue inflammation and damage.
The condition is seen worldwide but is more common in tropical and subtropical regions. Infections are particularly frequent in children, especially those under 6 years old. Cutaneous larva migrans is the most common tropical dermatosis, often acquired from contaminated beaches or soil. Visceral and ocular forms are most commonly caused by Toxocara canis and, less frequently, Toxocara cati, with a significant proportion of the population showing evidence of past infection.
Risk factors include contact with soil contaminated by dog or cat feces, poor hand hygiene, and geophagia. Children who play in contaminated environments are particularly at risk. Prevention focuses on avoiding direct contact with contaminated soil, wearing protective footwear, maintaining good hygiene, and regular deworming of pets.
The pathophysiology varies by form. In visceral larva migrans, eggs are ingested and hatch in the intestine, after which larvae migrate via the bloodstream to organs such as the liver, lungs, and central nervous system. These larvae may persist for years, causing chronic inflammation. In cutaneous larva migrans, larvae penetrate the skin but remain confined to the epidermis, migrating and forming characteristic tracks.
Cutaneous larva migrans, commonly caused by Ancylostoma braziliense, presents with intensely itchy, serpiginous, erythematous skin lesions that slowly advance over time. These lesions are most often found on the feet, legs, or areas exposed to contaminated ground. Visceral larva migrans may present with fever, fatigue, abdominal pain, cough, and hepatomegaly, while ocular larva migrans may cause visual disturbances, floaters, or even unilateral blindness due to retinal inflammation.
Physical examination findings vary with the syndrome. Cutaneous disease shows a creeping eruption on the skin, while visceral disease may show hepatomegaly, wheezing, or lymphadenopathy. Ocular disease may reveal retinal granulomas, uveitis, or optic nerve involvement on funduscopic examination.
Laboratory findings in visceral disease often include marked eosinophilia, leukocytosis, and elevated IgE levels. Serologic testing such as ELISA can support the diagnosis. Imaging studies may reveal hepatic or pulmonary lesions, while ocular disease is diagnosed primarily through ophthalmologic examination. Larvae are rarely identified directly in tissue samples.
Treatment depends on the clinical form. Cutaneous larva migrans is treated with antiparasitic agents such as albendazole or ivermectin, and symptoms usually resolve as the larvae die. Visceral larva migrans may not require treatment in mild cases, but severe disease is managed with albendazole or mebendazole. Ocular disease may also require antiparasitic therapy, often combined with corticosteroids to reduce inflammation, although treatment must be carefully managed to avoid worsening ocular damage.
Prognosis is generally good for cutaneous and most visceral cases, with spontaneous resolution common. However, ocular larva migrans carries a risk of permanent vision loss. Complications may include secondary bacterial infection in cutaneous disease, and in severe visceral cases, involvement of the brain, heart, or lungs.
- Published on
Infectious Disease and Microbiology - Legionnaires disease
Legionnaires’ disease is a form of pneumonia caused by gram-negative bacteria of the Legionellaceae family, most notably Legionella pneumophila. It was first identified in 1976 following an outbreak among attendees of an American Legion convention. A milder, non-pneumonic illness caused by the same organism is known as Pontiac fever. Together, these conditions are referred to as legionellosis.
The disease is relatively common among atypical pneumonias, accounting for a proportion of community-acquired pneumonia cases requiring hospitalization. It is associated with outbreaks linked to contaminated water systems such as cooling towers, air conditioning units, spas, and fountains. Cases occur more frequently in warmer months when such systems are widely used. Risk factors include older age, smoking, chronic lung disease, immunosuppression, and recent exposure to contaminated water sources or travel.
Legionella organisms are aerobic, intracellular bacteria that thrive in aquatic environments. They can proliferate in man-made water systems and are transmitted primarily through inhalation of aerosolized contaminated water. Once inhaled, the bacteria infect alveolar macrophages, where they replicate intracellularly. The immune response involves activation of T cells, which enhance macrophage-mediated killing.
Clinically, Legionnaires’ disease presents with high fever, malaise, myalgias, and headache, followed by respiratory symptoms such as cough, which may become productive, and chest pain. Gastrointestinal symptoms, including diarrhea and vomiting, are common and can help distinguish it from other pneumonias. Neurological symptoms such as confusion or encephalopathy may occur in severe cases. The incubation period is typically 2 to 10 days. In contrast, Pontiac fever presents as a self-limited febrile illness without pneumonia.
On physical examination, patients may have fever, tachypnea, and signs of lung consolidation such as rales. Relative bradycardia, hypotension, and altered mental status may also be present. Laboratory findings often include hyponatremia, elevated liver enzymes, and inflammatory markers. Diagnosis is supported by detection of Legionella antigen in urine, which is particularly useful early in the disease but mainly detects serogroup 1. Culture on specialized media and PCR testing may also be used.
Chest imaging typically shows patchy or lobar infiltrates, often involving the lower lobes, and pleural effusions may be present. Radiographic resolution can be slow and may lag behind clinical improvement.
Treatment involves prompt initiation of appropriate antibiotics. First-line therapy includes macrolides such as azithromycin or fluoroquinolones, with the latter preferred in severe cases. Intravenous therapy is used initially in hospitalized patients, followed by oral therapy once clinical improvement occurs. Treatment duration is generally 10–14 days, but longer courses may be required in immunocompromised individuals.
The prognosis depends on the patient’s overall health and comorbidities, with mortality rates ranging from 5% to 30%. Complications may include respiratory failure, multiorgan dysfunction, and extrapulmonary involvement such as myocarditis or renal failure. Early recognition and treatment are critical to improving outcomes.
- Published on
Infectious Disease and Microbiology - Laryngitis/Laryngotracheobronchitis (Croup)
Laryngitis refers to inflammation of the laryngeal mucosa, while laryngotracheobronchitis, commonly known as croup, involves inflammation of the subglottic airway, trachea, and bronchi. These conditions are most often caused by viral infections and typically present as part of an upper respiratory tract illness. Croup is particularly common in young children, especially between 3 months and 3 years of age, and tends to occur more frequently in boys.
The epidemiology reflects seasonal viral patterns. Laryngitis commonly occurs during winter in association with respiratory infections. Croup is most frequently caused by Parainfluenza virus type 1, especially in the fall, while Influenza virus and Respiratory syncytial virus contribute during winter and early spring. Other pathogens such as adenovirus, rhinovirus, enterovirus, and Mycoplasma pneumoniae may also be involved.
Risk factors for laryngitis include smoking, alcohol use, immunosuppression, and close contact with infected individuals. In croup, young age and possible variations in immune response play a major role. Prevention is mainly through avoidance of infected individuals and proper hand hygiene.
The underlying pathophysiology involves viral infection leading to inflammation, edema, and narrowing of the airway. In croup, subglottic swelling leads to airway obstruction, which is more pronounced in children due to their smaller airway diameter. This results in the characteristic stridor and respiratory distress.
Clinically, laryngitis presents with hoarseness, reduced voice pitch, and sometimes aphonia. In severe cases, airway obstruction may lead to stridor. Croup typically begins with fever followed by hoarseness and a distinctive “barking” cough. Inspiratory stridor, tachypnea, and chest wall retractions are common findings. In more severe cases, both inspiratory and expiratory stridor, wheezing, and signs of respiratory distress such as tachycardia and fatigue may develop.
Diagnosis is primarily clinical. Laboratory findings are usually normal, although hypoxemia may occur in severe cases. Imaging is not routinely required but may support the diagnosis. A classic anterior–posterior neck x-ray in croup shows subglottic narrowing known as the “steeple sign.”
Management depends on severity. Mild laryngitis is usually treated with supportive care such as humidified air, and medications are not required unless bacterial infection is suspected. In croup, corticosteroids such as dexamethasone are the mainstay of treatment and significantly improve symptoms. Nebulized epinephrine may be used in moderate to severe cases for temporary relief of airway obstruction, but patients require observation due to possible rebound symptoms. Supplemental oxygen is used in cases of hypoxemia, and severe cases may require intubation and mechanical ventilation.
The overall prognosis is excellent, with most cases resolving within a few days, although cough may persist longer. Complications are uncommon but may include airway obstruction and respiratory failure in severe croup. Rare complications include pneumothorax, pulmonary edema, and secondary infections. Long-term effects such as airway hyperreactivity or subglottic stenosis may occur in severe or recurrent cases.
